Predictive, Preventive and Personalized Medicine & Molecular Diagnostics

Prostate cancer and therapeutic implications

Prostatic carcinoma is the most prevalent cancer in men, and it is frequently multifocal in nature. There is on-going debate concerning the most appropriate system of tumour categorization and grading, as well as the best curative therapy options. The biologic, pathologic, prognostic and therapeutic implications of recent advances in the pathogenesis of multifocal prostatic cancer. Because of the multimodality of prostate cancer, appropriate clinical staging is challenging, and multiple adjustments have been made to improve prognostic accuracy. The clinical importance of the T2 sub staging is debatable, despite the fact that the revision is an improvement over earlier methods. The impact of tumour multimodality and clonal heterogeneity on the oncologic efficacy of innovative focused ablative techniques is also examined.